TCGA-CF-A5U8-01A-11R-A28M-07
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 13.10775296
- os_event
- false
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- OXIDATIVE_PHOSPHORYLATION+0.160
- BILE_ACID_METABOLISM+0.120
- KRAS_SIGNALING_DN+0.090
- PANCREAS_BETA_CELLS+0.090
- PEROXISOME+0.020
- XENOBIOTIC_METABOLISM+0.010
- REACTIVE_OXYGEN_SPECIES_PATHWAY+0.000
- ADIPOGENESIS-0.040
- FATTY_ACID_METABOLISM-0.050
- ESTROGEN_RESPONSE_EARLY-0.100
Top 10 suppressed
- E2F_TARGETS-0.650
- G2M_CHECKPOINT-0.610
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.520
- INFLAMMATORY_RESPONSE-0.490
- MTORC1_SIGNALING-0.490
- TNFA_SIGNALING_VIA_NFKB-0.480
- MITOTIC_SPINDLE-0.460
- IL6_JAK_STAT3_SIGNALING-0.450
- ALLOGRAFT_REJECTION-0.430
- UNFOLDED_PROTEIN_RESPONSE-0.380
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | ERR2278876 | — | — | 0.914 |
| 2 | SRR12202450 | — | — | 0.911 |
| 3 | SRR8943008 | — | — | 0.911 |
| 4 | TCGA-BH-A0HN-01A-11R-A10U-07 | — | B | 0.909 |
| 5 | SRR2016961 | — | — | 0.906 |
| 6 | SRR1516072 | — | — | 0.904 |
| 7 | TCGA-CF-A27C-01A-11R-A16R-07 | — | — | 0.904 |
| 8 | R247 | — | — | 0.902 |
| 9 | TCGA-E9-A245-01A-22R-A16F-07 | — | B | 0.901 |
| 10 | EPT0291 | EPN | EPN Tumor | 0.899 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 6 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| OXIDATIVE_PHOSPHORYLATION | 0.160 | Remibrutinib | — uncovered |
| BILE_ACID_METABOLISM | 0.120 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.090 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.090 | Cobimetinib | — uncovered |
| PEROXISOME | 0.020 | Idelalisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.010 | Inavolisib | — uncovered |